FIT Biotech Oy: Tekes issues a decision on the company's

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
FIT Biotech Oy: Tekes issues a decision on the company's rectification request related to Tekes's claim to capital loan related to the FIT Biotech HIV vaccine project in 2009-2010

FIT BIOTECH OY Company release

October 24, 2016 at 17.15 pm EET     

Tekes issues a decision on the company's rectification request related to Tekes's claim to capital loan related to the FIT Biotech HIV vaccine project in 2009-2010

According to FIT Biotech's company release of June 22,2016, Tekes (the Finnish Funding Agency for Innovation) had reclaimed part of FIT Biotech's Development of HIV vaccine project costs consisting of salaries, indirect employee expenses and overhead expenses which were earlier partly converted to grant. As announced, FIT Biotech submitted a rectification request on June 30, 2016 to which Tekes submitted an announcement of decision according to which company's rectification request had been partially accepted.

In the abovementioned decision Tekes stated that patent expenses of  273.393 euros reported to the Development of HIV vaccine project are to be re-visited to assess whether they are totally or partially acceptable.

In accordance with the decision submitted today to the company, Tekes reclaims the excess paid capital loan amounting to 98.627,20 euros with interest as of 18.3.2011. Based on the processed and partially accepted rectification request Tekes has accepted costs totaling to 4.536.246,90 euros. Of this, Tekes's capital loan has been 70% totalling to 3.175.372,80 euros. The amount of earlier withdrawn capital loan is 3.274.000 euros. Of this, Tekes is now in accordance with their decision reclaiming 98.627,20 euros.

The decision can be appealed.

FIT BIOTECH OY

Further information: Juha Vapaavuori Chairman of the Board of Director FIT Biotech Oy Tel: +358 50 372 0824 E-mail: juha.vapaavuori@sitra.fi

Certified Advisor: Aalto Capital Partners Oy, Tel. +358 40 587 7000

FIT Biotech in brief FIT Biotech Oy is a biotechnology company established in 1995 that develops and licenses its patented GTU® (Gene Transport Unit) vector technology for new-generation medical treatments. GTU® is a gene transport technology that meets an important medical challenge in the usability of gene therapy and DNA vaccines.

FIT Biotech applies GTU® technology in its drug development programmes. Application areas include cancer (gene therapy) and infectious diseases such as HIV and tuberculosis, as well as animal vaccines.

FIT Biotech shares are listed on the First North Finland market maintained by Nasdaq Helsinki Oy.

DISTRIBUTION: Nasdaq Helsinki Principal media www.fitbiotech.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Neutonic Sets Sights on U.S. with Walmart Expansion

Updated Category News Views 12

Neutonic Embarks on Major Expansion with Walmart Well, here we go. Neutonic is stepping up to the big leagues by planting its flag in nearly 1,000 Walmart stores across the U.S. This move lands them right in the thrumming heart of Walmart's new Mood & Mind beverage set. It's about time this brand brings its functional beverages to American shoppers already drained by...

Continue Reading
Wisconsin Chefs Transform Pizza with Crave Brothers Cheese

Updated Category News Views 4

Reimagining Pizza with Wisconsin's Best Cheeses It's not every day you see a pizza challenge that turns a staple of Friday nights into a gastronomic showcase. But that's exactly what's happening in Wisconsin as chefs flex their creativity using Crave Brothers Farmstead Cheese. This is no ordinary cheese-and-pepperoni affair—these culinary pros are cooking up pizzas with...

Continue Reading
Kroger, Imprint Team Up for AI-Driven Mastercard

Updated Category News Views 4

Kroger Teams Up with Imprint for New Credit Card Kroger’s at it again, folks. They're rolling out a shiny new Mastercard, and it's not just any plastic—it’s powered by the AI-driven platform Imprint. Now, what does this mean for you and me? Well, if you're a frequent flyer at Kroger aisles, you might want to pay attention because this card’s offering point...

Continue Reading
Texas A&M-San Antonio's Research Expansion Momentum

Updated Category News Views 4

Texas A&M-San Antonio's Rising Research Ambitions A rainy day in San Antonio and Texas A&M University-San Antonio seems to have set the stage for more than just another semester of record enrollment. They’ve just rolled in with an exhilarating $8 million in external grants this fiscal year, more than doubling last year’s haul of $3.6 million, in a bid to push their...

Continue Reading
Athlete Threats: Public Info Fuels Security Risks

Updated Category News Views 3

Public Exposure: The New Athlete Achilles' Heel Imagine sitting on millions while living in a glass house. That's the kind of predicament today's athletes find themselves in, thanks to the treasure trove of public information spilling their personal lives all over the internet. According to the latest Hush Intelligence Athlete Threat Report 2026, this very exposure has...

Continue Reading
Nelson-Jameson Boosts Cold Storage in California Move

Updated Category News Views 4

An Icy Boost for the West Coast Dairy Player Every now and then, a company gets its cold storage game just right. Nelson-Jameson has added fresh muscle to its Turlock facility in California, making waves with serious logistical upgrades. The company's dogged pursuit of better operational efficiency in dairy processing isn't just about bragging rights. It's plain old good...

Continue Reading
Varda Space's Dual Launch Signals Orbital Ambitions

Updated Category News Views 7

It's not every day you see two commercial rockets heading to orbit on the same ride, but that's precisely what Varda Space Industries just pulled off. With the W-8 and W-9 vehicles blasting off together, Varda is positioning itself for a leap in orbital operations. They've hitched a ride aboard SpaceX's Transporter-18 mission, and this is more than just a double...

Continue Reading
Concrete Pipe: Foundation of Modern Infrastructure

Updated Category News Views 8

Reinforced Concrete Pipes Hold Their Ground You know, it might not be the flashiest part of our infrastructure toolkit, but concrete pipe plays a mighty big role behind the scenes. Even in this age of shiny new tech and constantly evolving materials, the classic concrete pipe still packs a punch—especially when you demand something that'll last. Enter Stephanie Ward, a...

Continue Reading
Mitsubishi's Q3 Sales: SUVs Up, Mirage Out

Updated Category News Views 4

You ever notice how the market treats innovation and tradition like they’re these ever-spinning plates in a circus act? Take Mitsubishi Motors North America (MMNA). Their third-quarter report's got me both nodding in approval and scratching my head. Sure, they sold 18,543 vehicles—down 5.6% from the previous year. But don’t write 'em off just yet. The slumping...

Continue Reading
Ultrabench Revolutionizes AI Model Comparison Game

Updated Category News Views 3

Breaking Down the Messy AI Model Landscape Ultrabench.ai is here to drag AI model comparison out of the dark ages. Picture this: 309 AI models, ranked against a whopping 530 benchmarks, all served up on one plate. If you’re navigating the AI jungle, you’ll realize how Ultrabench is no small fish in this vast ocean. Consolidating Where Others Have Scattered There's a...

Continue Reading
re News Articles